| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sjogren Colleen | Chief Commercial Officer | C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 18 Jun 2025 | 0002017751 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Purchase | $90,350 | +50,000 | +161% | $1.81 | 81,000 | 16 Jun 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.795 to $1.82, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |
| F2 | Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. |